JP2018515552A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515552A5
JP2018515552A5 JP2017560243A JP2017560243A JP2018515552A5 JP 2018515552 A5 JP2018515552 A5 JP 2018515552A5 JP 2017560243 A JP2017560243 A JP 2017560243A JP 2017560243 A JP2017560243 A JP 2017560243A JP 2018515552 A5 JP2018515552 A5 JP 2018515552A5
Authority
JP
Japan
Prior art keywords
shbg
progestin
estrogen
kit
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017560243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515552A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/033024 external-priority patent/WO2016187269A1/en
Publication of JP2018515552A publication Critical patent/JP2018515552A/ja
Publication of JP2018515552A5 publication Critical patent/JP2018515552A5/ja
Priority to JP2021117119A priority Critical patent/JP2021169503A/ja
Pending legal-status Critical Current

Links

JP2017560243A 2015-05-18 2016-05-18 避妊用組成物ならびに有効性改善および副作用調節方法 Pending JP2018515552A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021117119A JP2021169503A (ja) 2015-05-18 2021-07-15 避妊用組成物ならびに有効性改善および副作用調節方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562163113P 2015-05-18 2015-05-18
US62/163,113 2015-05-18
US201562254999P 2015-11-13 2015-11-13
US62/254,999 2015-11-13
PCT/US2016/033024 WO2016187269A1 (en) 2015-05-18 2016-05-18 Contraceptive compositions and methods for improved efficacy and modulation of side effects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021117119A Division JP2021169503A (ja) 2015-05-18 2021-07-15 避妊用組成物ならびに有効性改善および副作用調節方法

Publications (2)

Publication Number Publication Date
JP2018515552A JP2018515552A (ja) 2018-06-14
JP2018515552A5 true JP2018515552A5 (https=) 2019-06-20

Family

ID=56116539

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017560243A Pending JP2018515552A (ja) 2015-05-18 2016-05-18 避妊用組成物ならびに有効性改善および副作用調節方法
JP2021117119A Pending JP2021169503A (ja) 2015-05-18 2021-07-15 避妊用組成物ならびに有効性改善および副作用調節方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021117119A Pending JP2021169503A (ja) 2015-05-18 2021-07-15 避妊用組成物ならびに有効性改善および副作用調節方法

Country Status (10)

Country Link
US (3) US20180125860A1 (https=)
EP (1) EP3297634A1 (https=)
JP (2) JP2018515552A (https=)
CN (1) CN107995864A (https=)
AU (2) AU2016264137B2 (https=)
BR (1) BR112017024783A2 (https=)
CA (1) CA2986039A1 (https=)
HK (1) HK1251938A1 (https=)
MX (1) MX2017014768A (https=)
WO (1) WO2016187269A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
US20200129524A1 (en) * 2017-03-15 2020-04-30 Agile Therapeutics, Inc. Personalized contraceptive formulations
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US4863738A (en) 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) * 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
CN1188189C (zh) 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6251956B1 (en) * 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
BR0015802B1 (pt) * 1999-11-24 2014-04-29 Agile Therapeutics Inc Sistema de administração de contraceptivo transdérmico, e, método para produzir um sistema de administração de contraceptivo transdérmico
ATE485837T1 (de) 2000-08-03 2010-11-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
JP4965263B2 (ja) * 2003-12-12 2012-07-04 バイエル ファーマ アクチエンゲゼルシャフト 浸透増強剤を必要としないホルモンの経皮送達
CN1672685A (zh) * 2004-03-26 2005-09-28 董可娟 一种新的避孕药物
US20100178323A1 (en) * 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
CA2704117C (en) 2007-11-02 2015-11-17 Acrux Dds Pty Ltd Transdermal delivery system
ES2734510T3 (es) * 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
CA2740004A1 (en) * 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
US9198919B2 (en) * 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
EP2410859A4 (en) * 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
EP2806862A2 (en) 2012-01-27 2014-12-03 Agile Therapeutics, Inc. Transdermal hormone delivery
EA030797B1 (ru) * 2012-12-21 2018-09-28 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Система трансдермальной доставки гормонов (варианты) и способы ее применения

Similar Documents

Publication Publication Date Title
JP2018515552A5 (https=)
US20250319102A1 (en) Contraceptive compositions and methods for improved efficacy and modulation of side effects
Abrams et al. Pharmacokinetic overview of Ortho Evra™/Evra™
EP1322336B1 (en) Method of increasing testosterone and related steroid concentrations in women
JP2013514984A5 (https=)
HUP0200416A2 (hu) Alacsony dózisú ösztrogénnel megszakított hormonpótlásos terápiára alkalmas gyógyászati készítmény
JPH08510993A (ja) ホルモン補充方法
SK18212001A3 (sk) Kit na zlepšenie zdravotného stavu žien
WO2007124250A3 (en) Methods of treating hot flashes with formulations for transdermal or transmucosal application
JPH09502194A (ja) 少なくとも１種のプロゲストーゲンおよび少なくとも１種のエストロゲンを含む、代替療法用製剤
AU2001285367A1 (en) Method of increasing testosterone and related steroid concentrations in women
TW200529862A (en) Extended use combination comprising estrogens and progestins
EP2283865A1 (en) Method of increasing testosterone and related steroid concentrations in women
Pozo et al. Ascertainment and treatment of delayed puberty
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
KR20080025168A (ko) 경구 단일상 피임제에 대한 신규 요법
Algin-Yapar et al. Transdermal spray in hormone delivery
CN101189015A (zh) 延长的雌激素定量给药避孕疗法
Huhtaniemi A hormonal contraceptive for men: how close are we?
Cagnacci et al. Contraception in wome n with metabolic conditions
US11376263B2 (en) Cyproterone acetate compositions and uses thereof
WO2008116825A2 (en) Compositions and method for treating pediatric hypogonadism
JP2019524846A5 (https=)
Liu et al. Advances in transdermal estrogen-only therapy for vasomotor symptoms
US20210386757A1 (en) Methods of Treating Menopausal Symptoms Using Low Dose Progesterone